Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

Logo
☰
  • Services ⌄
    • Histology
    • Pharmacology
    • Medical Device Testing
    • In Vitro Screening
    • Animal Model Development
    • Custom Assay Development
    • Vivarium Rental
    • Toxicology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Mini-pigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Career
    • Request a Quote

Biologics Stakeholders Seek Clearer Guidance on Post-Approval Changes

  • Post author:Sam
  • Post published:November 13, 2017
  • Post category:Drug GMP Report

The FDA’s draft guidance on post-approval manufacturing changes for biological products needs work to clarify how it fits with previous agency documents, according to written comments on the draft. Source:…

Continue ReadingBiologics Stakeholders Seek Clearer Guidance on Post-Approval Changes

483 Roundup: FDA Finds Faults During On-Site Inspections

  • Post author:Sam
  • Post published:November 13, 2017
  • Post category:Drug GMP Report

Problems with handling complaints, maintaining sterile production conditions and following up on testing crop up in reports of on-site inspections. Source: Drug GMP Report

Continue Reading483 Roundup: FDA Finds Faults During On-Site Inspections

Warning Letter Roundup: FDA Flags Six Firms for Numerous Violations

  • Post author:Sam
  • Post published:November 13, 2017
  • Post category:Drug GMP Report

Makers of APIs, compounded drugs, and dietary supplements draw warnings from the agency for a variety of GMP and other violations. Source: Drug GMP Report

Continue ReadingWarning Letter Roundup: FDA Flags Six Firms for Numerous Violations

FDA Releases New MAPP for the Review of Packaging Master Files

  • Post author:Sam
  • Post published:November 13, 2017
  • Post category:Drug GMP Report

The FDA updated its staff manual on Chemistry, Manufacturing and Controls reviews of drug master files for packaging materials. Source: Drug GMP Report

Continue ReadingFDA Releases New MAPP for the Review of Packaging Master Files

EMA’s PRAC Recommends New Safety Warnings, Side-Effect Labeling

  • Post author:Sam
  • Post published:November 13, 2017
  • Post category:Drug GMP Report

The European Medicines Agency’s pharmacovigilance panel made recommendations for updated label warnings for a variety of products. Source: Drug GMP Report

Continue ReadingEMA’s PRAC Recommends New Safety Warnings, Side-Effect Labeling

Top 5 Biosimilars Drug Stocks to Buy Right Now

  • Post author:Sam
  • Post published:November 12, 2017
  • Post category:BioPharma

During the presidential campaign of 2015-2016, one of the areas that got some of the largest scrutiny was drug pricing, and with good reason. Source: BioSpace

Continue ReadingTop 5 Biosimilars Drug Stocks to Buy Right Now

Pfizer to Hire Up to 400 in Michigan for 2018

  • Post author:Sam
  • Post published:November 12, 2017
  • Post category:BioPharma

Pfizer is planning to hire 200 new staffers and another 200 replacement workers in Michigan. Source: BioSpace

Continue ReadingPfizer to Hire Up to 400 in Michigan for 2018

Gates Pledges $100M to the Holy Grail of Science–Alzheimer's

  • Post author:Sam
  • Post published:November 12, 2017
  • Post category:BioPharma

The investment is not part of Gates’ philanthropic Bill & Melinda Gates Foundation and will be followed with another $50 million in a number of start-up ventures working in Alzheimer’s…

Continue ReadingGates Pledges $100M to the Holy Grail of Science–Alzheimer's

Novo Nordisk Lays Off 185 Employees, Hiring 70 in Commercial Reorg

  • Post author:Sam
  • Post published:November 12, 2017
  • Post category:BioPharma

After falling short of analysts' expectations in its latest quarter, Novo Nordisk is restructuring its commercial operations as it looks to fend off challenges to its products. Source: BioSpace

Continue ReadingNovo Nordisk Lays Off 185 Employees, Hiring 70 in Commercial Reorg

Nektar Stock Blows Up on Encouraging Data to Treat Difficult Cancers

  • Post author:Sam
  • Post published:November 12, 2017
  • Post category:BioPharma

The initial results were presented at the 2017 Society for Immunotherapy of Cancer (SITC) Annual Meeting. Source: BioSpace

Continue ReadingNektar Stock Blows Up on Encouraging Data to Treat Difficult Cancers
  • Go to the previous page
  • 1
  • …
  • 260
  • 261
  • 262
  • 263
  • 264
  • 265
  • 266
  • …
  • 610
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:

6042 Cornerstone Court W

Suite E

San Diego, CA 92121

Social:
© 2025 BioLegacy Research. All rights reserved.